| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.27 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |